Home Business Gilead Sciences (NASDAQ: GILD) Stocks Soar After Report Of Merger With AstraZeneca

Gilead Sciences (NASDAQ: GILD) Stocks Soar After Report Of Merger With AstraZeneca

Gilead Sciences Inc.(NASDAQ: GILD) stocks rose after several reports disclosed that UK-drugmaker AstraZeneca (NYSE: AZN) is in talks with Gilead Sciences for the potential merger.

It was also disclosed that there are no formal talks between the two companies. Gilead Sciences is currently not interested in merging or selling.

If the rumors between two companies would be true then this is the biggest merger of drugmakers. Shares of AstraZeneca dropped after the merger reports.

AstraZeneca shares dropped 2.84% at $52.32 during the trading session on Monday. It has a trading volume of 2.06 million as contrasted to the 3-months average volume of 5.36 million.

It has a day low range of 52.28 and a day high range of 53.00. AstraZeneca has a 52-weeks low range of 36.15 and 52-weeks high range of 57.44.

On the other side, Gilead Sciences stocks shot up 1.07% at $77.57 during the trading session on Monday. GILD has a day low and high range of 77.54-79.31, respectively.

It has recorded a drop of -9.77% from its 52-weeks low and moved up 27.39% from its 52-weeks high. It has a total market capitalization of 97.26 billion.

Sources disclosed that UK-drug maker AstraZeneca has approached Gilead Sciences about their potential merger. Investors attracted to Gilead Sciences after its drug remdesivir has shown a positive result in the treatment of COVID-19 patients.

Stay Connected

2,203FansLike
665FollowersFollow
3,436FollowersFollow

Must Read

Chrissy Teigen Admitted To Hospital

Model, author, and TV personality Chrissy Teigen has been admitted to the hospital due to complications in her pregnancy. Craving Cookbook author is expecting...

Related News

Tesla Inc. (NASDAQ: TSLA) Receives China Approval To Make Model 3 Vehicles

Tesla Inc. (NASDAQ: TSLA) announced Thursday it has got permission to build Model 3 vehicles in China. Earlier, it was disclosed that Tesla was...

Amazon (NASDAQ: AMZN) Roll Out Pilot Program For Regular Testing Of Its Workers

Amazon.com, Inc has started a program for the regular testing of its workers. The pilot testing program is currently in the refining process. Amazon...

Novavax Inc. (NASDAQ: NVAX) Receives $60M Funding From DoD For COVID-19 Vaccine Candidate

Novavax Inc. (NASDAQ: NVAX) declared Friday that the US Department of Defense has awarded the company a contract to make its NVX-CoV2373 COVID-19 candidate....

SoftBank (SFTBY) Starts $100M Startup Fund For Minorities

Softbank Group Corp. (SFTBY) declared it has decided to start a $100 million (£80m) startup fund for the entrepreneurs of color. SoftBank is the...

Alphabet Inc (NASDAQ: GOOGL) Is Being Sued For Allegedly Invading Users Privacy

Alphabet Inc's Google (NASDAQ: GOOGL) has been accused of collecting the users' information about what they view online & where they browse despite using...